FI10194U1 - Setilistaattia sisältäviä koostumuksia - Google Patents
Setilistaattia sisältäviä koostumuksiaInfo
- Publication number
- FI10194U1 FI10194U1 FIU20124262U FIU20124262U FI10194U1 FI 10194 U1 FI10194 U1 FI 10194U1 FI U20124262 U FIU20124262 U FI U20124262U FI U20124262 U FIU20124262 U FI U20124262U FI 10194 U1 FI10194 U1 FI 10194U1
- Authority
- FI
- Finland
- Prior art keywords
- cetilate
- compositions containing
- compositions
- formulations
- relates
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000009472 formulation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 1
- MVCQKIKWYUURMU-UHFFFAOYSA-N cetilistat Chemical compound C1=C(C)C=C2C(=O)OC(OCCCCCCCCCCCCCCCC)=NC2=C1 MVCQKIKWYUURMU-UHFFFAOYSA-N 0.000 abstract 1
- 229950002397 cetilistat Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
- 230000037221 weight management Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Logic Circuits (AREA)
- Manipulation Of Pulses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1122213.0A GB201122213D0 (en) | 2011-12-23 | 2011-12-23 | Compositions |
| GBGB1203082.1A GB201203082D0 (en) | 2012-02-22 | 2012-02-22 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI10194U1 true FI10194U1 (fi) | 2013-08-20 |
Family
ID=47560448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIU20124262U FI10194U1 (fi) | 2011-12-23 | 2012-12-20 | Setilistaattia sisältäviä koostumuksia |
Country Status (8)
| Country | Link |
|---|---|
| AU (1) | AU2012101841A4 (fi) |
| DK (1) | DK201200198Y4 (fi) |
| ES (1) | ES2417408B1 (fi) |
| FI (1) | FI10194U1 (fi) |
| FR (1) | FR2984745B3 (fi) |
| IE (1) | IES86183B2 (fi) |
| IT (1) | ITTO20121118A1 (fi) |
| NL (1) | NL2009995C2 (fi) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6004996A (en) * | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
| AR022204A1 (es) * | 1999-01-08 | 2002-09-04 | Norgine Bv | Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende. |
| EP1897558B1 (en) * | 2005-06-09 | 2013-09-04 | Norgine BV | Solid preparation of 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-one |
| JP2010254623A (ja) * | 2009-04-24 | 2010-11-11 | Takeda Chem Ind Ltd | ベンゾオキサジノン化合物の結晶 |
-
2012
- 2012-12-17 AU AU2012101841A patent/AU2012101841A4/en not_active Ceased
- 2012-12-17 NL NL2009995A patent/NL2009995C2/en not_active IP Right Cessation
- 2012-12-20 FI FIU20124262U patent/FI10194U1/fi not_active IP Right Cessation
- 2012-12-20 FR FR1262391A patent/FR2984745B3/fr not_active Expired - Lifetime
- 2012-12-20 DK DKBA201200198U patent/DK201200198Y4/da not_active IP Right Cessation
- 2012-12-20 ES ES201231973A patent/ES2417408B1/es not_active Expired - Fee Related
- 2012-12-20 IT IT001118A patent/ITTO20121118A1/it unknown
- 2012-12-20 IE IES20120556A patent/IES86183B2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012101841A4 (en) | 2013-01-17 |
| IES20120556A2 (en) | 2013-05-08 |
| DK201200198Y4 (da) | 2018-09-17 |
| FR2984745B3 (fr) | 2017-12-22 |
| ES2417408B1 (es) | 2014-11-26 |
| FR2984745A3 (fr) | 2013-06-28 |
| ES2417408A2 (es) | 2013-08-07 |
| ITTO20121118A1 (it) | 2013-06-24 |
| IES86183B2 (en) | 2013-05-08 |
| NL2009995A (en) | 2013-06-26 |
| ES2417408R1 (es) | 2013-10-15 |
| DK201200198U1 (en) | 2013-04-12 |
| NL2009995C2 (en) | 2013-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180103A1 (ar) | مركب صيدلاني | |
| CY1119762T1 (el) | C-17-ετεροαρυλικα παραγωγα ελαιολικου οξεος και μεθοδοι χρησης αυτων | |
| NZ706739A (en) | Substituted benzene compounds | |
| EA201500652A1 (ru) | Дифторметилникотиновые инданилкарбоксамиды | |
| EA201490357A1 (ru) | Индазолы | |
| PH12014502697B1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| IN2014MN02106A (fi) | ||
| IN2014MN02598A (fi) | ||
| UA112317C2 (uk) | Похідні 2-(1,2,3-триазол-2-іл)бензаміду та 3-(1,2,3-триазол-2-іл)піколінаміду як антагоністи рецептора орексину | |
| EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
| EA201490037A1 (ru) | Антагонисты trpv4 | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| EA201390163A1 (ru) | Гетеробициклические производные в качетстве ингибиторов hcv | |
| MY167898A (en) | Co-crystals and salts of ccr3-inhibitors | |
| IN2014CN01216A (fi) | ||
| CL2013003056A1 (es) | Compuestos derivados de (fenil o piridin)-etinil-(piridin o pirimidin) sustituido; composición farmacéutica que los comprende; proceso de preparación de esto; y su uso en el tratamiento de la esquizofrenia o enfermedades cognitivas. | |
| PH12015501054A1 (en) | Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides | |
| MX346980B (es) | Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona. | |
| UY33528A (es) | Derivados de oxadiazoles y de piridazinas, su preparacion y su aplicacion en terapeutica | |
| MX374323B (es) | Compuestos de heteroarilo y métodos de uso de los mismos. | |
| IN2014CN01217A (fi) | ||
| EA201390488A1 (ru) | Новые агонисты gpr 119 | |
| IN2015DN02109A (fi) | ||
| MX2015004312A (es) | Formulacion de aroma y fragancia (i). | |
| MX2013009386A (es) | Nuevos compuestos de azaespirodecanona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGU | Utility model registered |
Ref document number: 10194 Country of ref document: FI Kind code of ref document: U1 |
|
| MMU | Utility model lapsed |